These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1548033)

  • 21. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny.
    Silverman M; Kua L; Tanca A; Pala M; Palomba A; Tanes C; Bittinger K; Uzzau S; Benoist C; Mathis D
    Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9671-9676. PubMed ID: 28831005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
    Singer SM; Tisch R; Yang XD; Sytwu HK; Liblau R; McDevitt HO
    Diabetes; 1998 Oct; 47(10):1570-7. PubMed ID: 9753294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the major histocompatibility complex on development of autoimmune diabetes in RIP-B7.1 mice.
    Wong FS; Du W; Thomas IJ; Wen L
    Diabetes; 2005 Jul; 54(7):2032-40. PubMed ID: 15983204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profile.
    van Halteren AG; Mosselman B; Roep BO; van Eden W; Cooke A; Kraal G; Wauben MH
    J Immunol; 2000 Nov; 165(10):5544-51. PubMed ID: 11067908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of type 1 diabetes by gene therapy.
    Tian C; Bagley J; Cretin N; Seth N; Wucherpfennig KW; Iacomini J
    J Clin Invest; 2004 Oct; 114(7):969-78. PubMed ID: 15467836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
    Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
    J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.
    Katz J; Benoist C; Mathis D
    Eur J Immunol; 1993 Dec; 23(12):3358-60. PubMed ID: 8258349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
    Brenden N; Rietz C; Böhme J
    Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: additive, but unequal, involvement of multiple APC subtypes.
    Johnson EA; Silveira P; Chapman HD; Leiter EH; Serreze DV
    J Immunol; 2001 Aug; 167(4):2404-10. PubMed ID: 11490031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
    Gearon CL; Hussain MJ; Vergani D; Peakman M
    Diabetologia; 1997 Dec; 40(12):1388-95. PubMed ID: 9447945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: an in vitro insight into the pathogenesis of lymphocytic insulitis in nonobese diabetic mice.
    Formby B; Miller N
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2438-42. PubMed ID: 2138777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.
    Wherrett DK; Singer SM; McDevitt HO
    Diabetes; 1997 Dec; 46(12):1970-4. PubMed ID: 9392482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
    von Herrath M; Holz A
    J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.
    Kay TW; Parker JL; Stephens LA; Thomas HE; Allison J
    J Immunol; 1996 Oct; 157(8):3688-93. PubMed ID: 8871671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.
    French MB; Allison J; Cram DS; Thomas HE; Dempsey-Collier M; Silva A; Georgiou HM; Kay TW; Harrison LC; Lew AM
    Diabetes; 1997 Jan; 46(1):34-9. PubMed ID: 8971078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
    Lee MS; Mueller R; Wicker LS; Peterson LB; Sarvetnick N
    J Exp Med; 1996 Jun; 183(6):2663-8. PubMed ID: 8676087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.